A Specific Chemical Difference Between the Globins of Normal Human and Sickle-Cell Anæmia Hæmoglobin
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sickle cell anemia is caused by homozygosity of the beta-S (βS) allele (located on chromosome 11p15.5), which differs from the wild-type β-allele by a single nucleotide polymorphism dbSNP Rs334(T;T) in which GTG is substituted for GAG in the sixth codon of the β-globin gene (1, 3, 5, 6).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [5]
Citations
Cites
Sickle Cell Anemia, a Molecular Disease
Pauling, L., Itano, H. A., Singer, S. J., & Wells, I. C. (1949) · Science · doi:10.1126/science.110.2865.543 · Cited by 2,319
The free amino groups of haemoglobins
Porter, R., & Sanger, F. (1948) · Biochemical Journal · doi:10.1042/bj0420287 · Cited by 382
The Inheritance of Sickle Cell Anemia
Neel, J. V. (1949) · Science · doi:10.1126/science.110.2846.64 · Cited by 360
�ber Papierionophorese bei Spannungsgef�llen von 50 Volt/cm
Michl, H. (1951) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/bf00900846 · Cited by 253
State of Hæmoglobin in Sickle-Cell Anæmia
PERUTZ, M. F., & MITCHISON, J. M. (1950) · Nature · doi:10.1038/166677a0 · Cited by 221
X-Ray and Solubility Studies of the Hæmoglobin of Sickle-Cell Anæmia Patients
PERUTZ, M. F., LIQUORI, A. M., & EIRICH, F. (1951) · Nature · doi:10.1038/167929a0 · Cited by 187
Sulphydryl groups in haemoglobins
Ingram, V. M. (1955) · Biochemical Journal · doi:10.1042/bj0590653 · Cited by 94
Self-citationAMINO ACID COMPOSITION OF HEMOGLOBINS OF NORMAL NEGROES AND SICKLE-CELL ANEMICS
Schroeder, W. A., Kay, L. M., Wells, I. C., Gerke, C., & Moss, J. (1950) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50947-4 · Cited by 67
Amino-Acid Composition of Four Different Kinds of Human Hæmoglobin
Huisman, T. H. J., Jonxis, J. H. P., & Schaaf, P. (1955) · Nature · doi:10.1038/175902a0 · Cited by 34
The sulfhydryl groups of four different human haemoglobins
Hommes, F. A., Santema-Drinkwaard, J., & Huisman, T. H. J. (1956) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(56)90358-4 · Cited by 25
Cited by
Items 201–300 of 894
Luck, L. R., Zeng, L., Hiti, A. L., Weinberg, K. I., & Malik, P. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.02.003 · Cited by 38
Toward gene therapy for disorders of globin synthesis
Tisdale, J. F., & Sadelain, M. (2001) · Seminars in Hematology · doi:10.1016/s0037-1963(01)90033-2 · Cited by 39
Estimation of fetal hemoglobin levels in individual red cells via fluorescence image cytometry
Horiuchi, K., Osterhout, M. L., Kamma, H., Bekoe, N. A., & Hirokawa, K. J. (1995) · Cytometry · doi:10.1002/cyto.990200310 · Cited by 34
Aich, A., Jones, M. K., & Gupta, K. (2019) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000491 · Cited by 39
Li, C., Ding, L., Sun, C.-W., Wu, L.-C., Zhou, D., Pawlik, K. M., Khodadadi-Jamayran, A., Westin, E., Goldman, F. D., & Townes, T. M. (2016) · Scientific Reports · doi:10.1038/srep30422 · Cited by 30
“Established SCD iPSC colonies were characterized by (1) PCR to examine residual reprogramming vectors (Fig.”
ResultAisiku, I. P., Penberthy, L. T., Smith, W. R., Bovbjerg, V. E., McClish, D. K., Levenson, J. L., Roberts, J. D., & Roseff, S. D. (2007) · PubMed Central · Cited by 36
Control gene mutation as a possible explanation of certain haptoglobin phenotypes.
Wc, P., & Bearn, A. G. (1963) · PubMed Central · Cited by 36
Gene therapy for genetic diseases: challenges and future directions
Beibei, Q. I. E., Tuo, J., Chen, F., Ding, H., & Lyu, L. (2025) · MedComm · doi:10.1002/mco2.70091 · Cited by 45
Hartley, T., Balci, T. B., Rojas, S. K., Eaton, A. J., Canada, C., Dyment, D. A., & Boycott, K. M. (2018) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31662 · Cited by 41
“Since the first publications of heritable human gene mutations over 40 years ago (Ingram, 1956; Orkin et al., 1978), we have made remarkable progress in understanding genetic diseases.”
BackgroundAneni, E. C., Hamer, D. H., & Gill, C. J. (2013) · Tropical Medicine & International Health · doi:10.1111/tmi.12056 · Cited by 35
Prevalence of the Sickle Cell Trait in Gabon: A nationwide study
Délicat-Loembet, L. M., Elguero, É., Arnathau, C., Durand, P., Ollomo, B., Ossari, S., Mezui-Me-Ndong, J., Mboro, T. M., Becquart, P., Nkoghe, D., et al. (2014) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2014.04.003 · Cited by 35
Amino Acid Composition and Amino-Terminal Sequence of Yeast Enolase
Malmström, B. G., KIMMEL, J. R., & Smith, E. L. (1959) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98140-8 · Cited by 35
Abnormal Human Hæmoglobins: Human Hæmoglobin E: the Chemical Effect of Gene Mutation
Hunt, J. A., & Ingram, V. M. (1959) · Nature · doi:10.1038/184870a0 · Cited by 35
Self-citationA world in one dimension: Linus Pauling, Francis Crick and the central dogma of molecular biology.
Strasser, B. J. (2006) · PubMed · Cited by 34
Casanova, J. (2025) · Journal of Human Immunity · doi:10.70962/jhi.20250001 · Cited by 36
“Despite the avalanche of sensational achievements by molecular Mendelians, from Linus Pauling and Vernon Ingram ’ s discovery of the molecular basis of sickle cell disease onward (4, 5), some modern biometricians still do not fully appreciate the importance of inborn errors.”
Use of genome-editing tools to treat sickle cell disease
Tasan, I., Jain, S., & Zhao, H. (2016) · Human Genetics · doi:10.1007/s00439-016-1688-0 · Cited by 36
“Since the identification of the causal monogenic mutation in 1956 by Ingram (1956), genetics and regulation of the implicated genes have been an area of intensive research.”
Emerging pharmacotherapeutic approaches for the management of sickle cell disease
Torres, L. S., & Conran, N. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1548610 · Cited by 36
Sickle Cell Disease in the Emergency Department
Lovett, P. B., Sule, H. P., & Lopez, B. L. (2014) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2014.04.011 · Cited by 44
Animal models of β-hemoglobinopathies: utility and limitations
McColl, B., & Vadolas, J. (2016) · Journal of Blood Medicine · doi:10.2147/jbm.s87955 · Cited by 37
“Ingram 4 examined the tryptic peptides of normal and sickle Hb and identified a single fragment, unique to HbS, that displayed altered charge characteristics.”
Advanced analytical methods for hemoglobin variants
Wada, Y. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00558-5 · Cited by 34
de Llano, J. J. M., & Manning, J. M. (1994) · Protein Science · doi:10.1002/pro.5560030806 · Cited by 34
Weisberger, A. S. (1962) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.48.1.68 · Cited by 34
Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13
Mpollo, M. E. M., Brandt, E. B., Shanmukhappa, S. K., Arumugam, P. I., Tiwari, S., Loberg, A., Pillis, D. M., Rizvi, T. A., Lindsey, M., Jonck, B., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77250 · Cited by 34
“It is caused by a mutation in the β-globin gene that results in sickle-shaped rbc during deoxygenation (1, 2).”
BackgroundHepatobiliary Manifestations of Sickle Cell Anemia
Issa, H. (2010) · Gastroenterology Research · doi:10.4021/gr2010.01.1332 · Cited by 34
Time resolved absorption study of the reaction of hydroxyurea with sickle cell hemoglobin
Kim‐Shapiro, D. B., King, S., Bonifant, C. L., Kolibash, C. P., & Ballas, S. K. (1998) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(97)00132-3 · Cited by 33
Separation of Specific Glutamate- and Glutamine-activating Enzymes from Escherichia coli
Lazzarini, R. A., & Mehler, A. H. (1964) · Biochemistry · doi:10.1021/bi00898a009 · Cited by 33
Potential therapeutic action of nitrite in sickle cell disease
Wajih, N., Basu, S., Jailwala, A., Kim, H. W., Ostrowski, D., Perlegas, A. S., Bolden, C. A., Buechler, N. L., Gladwin, M. T., Caudell, D. L., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.05.006 · Cited by 33
Fetal hemoglobin during infancy and in sickle cell adults.
Edoh, D. A., Antwi‐Boasiako, C., & Amuzu, D. S. Y. (2006) · African Health Sciences · doi:10.5555/afhs.2006.6.1.51 · Cited by 50
“African Health Sciences 2006; 6(1): 51- 54”
Why are bacteria different from eukaryotes?
Theriot, J. A. (2013) · BMC Biology · doi:10.1186/1741-7007-11-119 · Cited by 34
“In sickle-cell disease, a single point mutation in hemoglobin changes one charged residue on the surface to a neutral residue [61], and now in this dense cellular bag of the erythrocyte, filled almost entirely with one protein, you have a condition where the oxygen-depleted form of hemoglobin is able to self-assemble…”
BackgroundMuskiet, F. D., & Muskiet, F. A. J. (1984) · Clinica Chimica Acta · doi:10.1016/0009-8981(84)90095-0 · Cited by 32
Biochemical and functional properties of recombinant human sickle hemoglobin expressed in yeast.
de Llano, J. J. M., Jones, W. M., Schneider, K., Chait, B. T., Manning, J. M., Rodgers, G. P., Benjamin, L. J., & Weksler, B. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74210-0 · Cited by 32
Human Molecular Genetics Has Not Yet Contributed to Measurable Public Health Advances
Paneth, N., & Vermund, S. H. (2018) · Perspectives in biology and medicine · doi:10.1353/pbm.2018.0063 · Cited by 31
Treating Rare Diseases in Africa: The Drugs Exist but the Need Is Unmet
Luzzatto, L., & Makani, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.770640 · Cited by 32
“…coined when it was discovered that the basis of SCD was a structural abnormality in the haemoglobin molecule in red cells (Pauling et al., 1949) (Ingram, 1956); then one allele of a DNA restriction fragment length polymorphism was the first found to be genetically linked to the haemoglobin S…”
BackgroundAthanassiou, G., Moutzouri, A. G., Kourakli, A., & Zoumbos, N. C. (2006) · PubMed · Cited by 31
Asakura, T., Mattiello, J. A., Obata, K., Asakura, K., Reilly, M. P., Tomassini, N., Schwartz, E., & Ohene‐Frempong, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12589 · Cited by 34
Gene Replacement Therapy for Sickle Cell Disease and Other Blood Disorders
Townes, T. M. (2008) · Hematology · doi:10.1182/asheducation-2008.1.193 · Cited by 34
A neuroglobin-overexpressing transgenic mouse
Khan, A. A., Sun, Y., Jin, K., Mao, X. O., Chen, S., Ellerby, L., & Greenberg, D. A. (2007) · Gene · doi:10.1016/j.gene.2007.02.044 · Cited by 35
“O2-binding proteins were the first proteins for which the three-dimensional crystal structure was determined (myoglobin) (Kendrew et al., 1958) and the first in which a single amino acid substitution was shown to be the cause of a disease (hemoglobin in sickle-cell disease) (Ingram, 1956).”
BackgroundWilliams, D. C., & Whitaker, J. R. (1969) · PLANT PHYSIOLOGY · doi:10.1104/pp.44.11.1574 · Cited by 31
OGAWA, H., Gomi, T., Takata, Y., Date, T., & Fujioka, M. (1997) · Biochemical Journal · doi:10.1042/bj3270407 · Cited by 31
HEMOGLOBIN NAGASAKI (αA/2 β17/2Glu) A NEW ABNORMAL HUMAN HEMOGLOBIN FOUND IN ONE FAMILY IN NAGASAKI
Maekawa, M., MAEKAWA, T., Fujiwara, N., Tabara, K., & Matsuda, G. (1970) · International Journal of Protein Research · doi:10.1111/j.1399-3011.1970.tb01671.x · Cited by 30
Genetics of plasma transferrins in the mouse
Cohen, B. L. (1960) · Genetics Research · doi:10.1017/s0016672300000409 · Cited by 31
Applications of high-throughput DNA sequencing to benign hematology
Sankaran, V. G., & Gallagher, P. G. (2013) · Blood · doi:10.1182/blood-2013-07-460337 · Cited by 34
Joint disease-specificity at the regulatory base-pair level
Muthuirulan, P., Zhao, D., Young, M., Richard, D. J., Liu, Z., Emami, A., Portilla, G., Hosseinzadeh, S., Cao, J., Maridas, D. E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24345-9 · Cited by 34
Life-Threatening Complications of Sickle Cell Disease in Children
Mills, M. L. (1985) · JAMA · doi:10.1001/jama.1985.03360110077028 · Cited by 32
Modulation of the Phenotypic Diversity of Sickle Cell Anemia
Steinberg, M. H. (1996) · Hemoglobin · doi:10.3109/03630269609027906 · Cited by 30
Taylor, D. J., & Johnson, J. E. (2005) · Protein Science · doi:10.1110/ps.041054605 · Cited by 29
“Other point mutations that alter protein–protein interactions such as sickle cell anemia, the result of a glutamate to valine mutation in hemoglobin, are well documented (Ingram 1956).”
BackgroundMani, S., & Duffy, T. P. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90336-n · Cited by 30
Peptide maps obtained with tryptic digests of the proteins of some strains of tobacco mosaic virus
Woody, B. R., & Knight, C. A. (1959) · Virology · doi:10.1016/0042-6822(59)90128-x · Cited by 30
Heme-mediated cell activation: the inflammatory puzzle of sickle cell anemia
da Guarda, C. C., Santiago, R. P., Fiuza, L. M., Aleluia, M. M., Ferreira, J. R. D., Figueiredo, C. V. B., Yahouédéhou, S. C. M. A., de Oliveira, R. M., Lyra, I. M., & Gonçalves, M. D. S. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1327809 · Cited by 35
“This produces the Hb variant S (HbS; α2β2), forming long polymers when exposed to low oxygen concentrations [1, 2, 3] which consequently provokes the deformation of erythrocytes that participate in the pathophysiological mechanism of SCA [4].”
BackgroundGenetic therapies for the first molecular disease
Doerfler, P. A., Sharma, A., Porter, J. S., Zheng, Y., Tisdale, J. F., & Weiss, M. J. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146394 · Cited by 31
“In 1949, Pauling and colleagues noted abnormalities in the properties of sickle hemoglobin (HbS), which were shown by Ingram in 1956 to result from altered amino acid composition, distinguishing SCD as “the first molecular disease” (2, 3).”
BackgroundKinetics of Increased Deformability of Deoxygenated Sickle Cells upon Oxygenation
Huang, Z., Hearne, L., Irby, C. E., King, S. B., Ballas, S. K., & Kim‐Shapiro, D. B. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74661-x · Cited by 28
“Sickle cell anemia is caused by the replacement of glutamate by valine at the sixth position of the b-globin chain (Pauling et al., 1949; Ingram, 1956).”
BackgroundWhorton, C. M., Hudgins, P. C., & Conners, J. J. (1961) · New England Journal of Medicine · doi:10.1056/nejm196112212652504 · Cited by 29
Allen, G. (1980) · Biochemical Journal · doi:10.1042/bj1870565 · Cited by 29
Mandal, A. K., Mitra, A., & Das, R. (2020) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-41769-7_12 · Cited by 30
Defining the gene: an evolving concept.
Carlson, E. A. (1991) · Europe PMC (PubMed Central) · Cited by 28
Sankaranarayanan, K. (1991) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(91)90027-s · Cited by 29
RNA and polypeptide homology among murine coronaviruses
Cheley, S., Morris, V. L., Cupples, M. J., & Anderson, R. (1981) · Virology · doi:10.1016/0042-6822(81)90113-6 · Cited by 28
“Since the migrational characteristics of a peptide may be altered by a single amino acid substitution (Ingram, 1956; Hunt and Ingram, 1959), we interpret the above data as indicating a high degree of interstrain homology among nucleocapsid N proteins of murine coronaviruses.”
BackgroundOverview of Sickle Cell Anemia Pathophysiology
Steinberg, M. H. (2016) · Springer eBooks · doi:10.1007/978-3-319-06713-1_3 · Cited by 31
Consumer health informatics: From genomics to population health
McDaniel, A. M., Schutte, D. L., & Keller, L. O. (2008) · Nursing Outlook · doi:10.1016/j.outlook.2008.06.006 · Cited by 30
Diefenbacher, M., Thorsteinsdottir, H. B., & Spang, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.215657 · Cited by 28
Locus assignment of alpha-globin structural mutations by hybrid-selected translation.
Liebhaber, S. A., & Cash, F. E. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111698 · Cited by 27
Rosemblatt, M. S., Margolies, M. N., Cannon, L. E., & Haber, E. (1975) · Analytical Biochemistry · doi:10.1016/0003-2697(75)90516-3 · Cited by 27
Tromp, G., & Kuivaniemi, H. (2009) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2009.08.010 · Cited by 27
Antwi‐Boasiako, C., Frimpong, E., Ababio, G. K., Dzudzor, B., Ekem, I. A. E., Gyan, B., Sodzi-Tettey, N. A., & Antwi, D. K. (2015) · Ghana Medical Journal · doi:10.4314/gmj.v49i2.7 · Cited by 32
“The most important of these is a high level of hemoglobin F (HbF) in the erythrocytes.(17) The first insight into the role of foetal hemoglobin in the clinical manifestations of SCD was made by a pediatrician, Janet Watson.”
BackgroundGhatpande, S. S., Choudhary, P. K., Quinn, C. T., & Goodman, S. R. (2008) · Experimental Biology and Medicine · doi:10.3181/0805-s-149 · Cited by 26
Hemoglobin E, malaria and natural selection
Ha, J., Martinson, R., Iwamoto, S. K., & Nishi, A. (2019) · Evolution Medicine and Public Health · doi:10.1093/emph/eoz034 · Cited by 29
“HbS results from the switch of a glutamic acid to valine at the sixth codon of gene encoding b-globin [28].”
BackgroundRupon, J. W., Domingo, S. R., Smith, S. V., Gummadi, B. K., Shields, H. W., Ballas, S. K., King, S. B., & Kim‐Shapiro, D. B. (2000) · Biophysical Chemistry · doi:10.1016/s0301-4622(99)00132-5 · Cited by 26
Ellsworth, D. L., Manolio, T. A., & Mhs (1999) · Annals of Epidemiology · doi:10.1016/s1047-2797(98)00047-7 · Cited by 26
Mechanisms in genetic diseases of man
McKusick, V. A. (1957) · The American Journal of Medicine · doi:10.1016/0002-9343(57)90119-5 · Cited by 26
Basu, A., Saha, S., Karmakar, S., Chakravarty, S., Banerjee, D., Dash, B. P., & Chakrabarti, A. (2013) · PROTEOMICS · doi:10.1002/pmic.201300177 · Cited by 25
“This mutation leads to production of sickle cell anemia hemoglobin (Hb), HbS instead of normal Hb, HbA [1].”
BackgroundResearch in Sickle Cell Disease: From Bedside to Bench to Bedside
Cisneros, G. S., & Thein, S. L. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000584 · Cited by 26
Effect of Hemoglobin Concentration on Nucleation and Polymer Formation in Sickle Red Blood Cells
Corbett, J. D., Mickols, W., & Maestre, M. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2708 · Cited by 25
Behe, M. J., & Englander, S. W. (1979) · Journal of Molecular Biology · doi:10.1016/0022-2836(79)90254-7 · Cited by 25
Micro-scale peptide mapping method for identification of variant proteins
Watanabe, S., & Yoshida, A. (1971) · Biochemical Genetics · doi:10.1007/bf00485672 · Cited by 25
Mass Spectrometry in the Characterization of Variant Hemoglobins
Shackleton, C. H. L., & Witkowska, H. E. (1994) · Springer eBooks · doi:10.1007/978-1-4899-1748-5_4 · Cited by 25
Fingerprinting of glutenin and gliadin
Ewart, J. A. D. (1966) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.2740170107 · Cited by 25
Sickle cell disease: challenges and progress
Parise, L. V., & Berliner, N. (2016) · Blood · doi:10.1182/blood-2015-12-674606 · Cited by 25
“Details of the mutation (replacement of glutamic acid with valine in the 6th position of the hemoglobin [Hb] b-chain) were first described by Ingram in 1956.(4) Despite these early discoveries, the life expectancy of sickle cell patients only began to improve significantly within the last 30 years, first with the intr…”
BackgroundSickle Cell Disease in the Emergency Department
Lovett, P. B., Sule, H. P., & Lopez, B. L. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.08.009 · Cited by 29
Promising Therapies in Sickle Cell Disease
Raghupathy, R., & Billett, H. H. (2009) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/187152909787581354 · Cited by 25
Stroke in sickle cell anemia patients: A need for multidisciplinary approaches
Menaa, F. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.05.006 · Cited by 30
“a point mutation) which changes the glutamic acid for valine [b6Glu (GAG)/Val (GTG)] at the sixth position of the amino acid sequence of the b-globin chain of hemoglobin A, a heterotetramer composed of two a-hemoglobin chains and two b-hemoglobin chains [4].”
BackgroundUsing 5′-PTMs to repair mutant β-globin transcripts
Kierlin-Duncan, M. N., & Sullenger, B. A. (2007) · RNA · doi:10.1261/rna.525607 · Cited by 27
Kawaguchi, M., Yasumasu, S., Shimizu, A., Kudo, N., Sano, K., Iuchi, I., & Nishida, M. (2013) · Journal of Experimental Biology · doi:10.1242/jeb.069716 · Cited by 23
“For example, (i) GAG (Val) to GTG (Glu) substitution in the sixth codon of human β-globin gene results in sickle cell disease (Ingram, 1956; Ingram, 1957); (ii) single amino acid substitutions in carotenoid biosynthetic enzymes alter substrate specificity and reaction selectivity to produce a…”
BackgroundCannas, G., Poutrel, S., & Thomas, X. (2017) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2017.015 · Cited by 27
Ferranti, P., Sannolo, N., Mamone, G., Fiume, I., Carbone, V., Törnqvist, M., Bergman, Å., & Malorni, A. (1996) · Carcinogenesis · doi:10.1093/carcin/17.12.2661 · Cited by 24
Effects of Iron Nitrosylation on Sickle Cell Hemoglobin Solubility
Xu, X., Lockamy, V. L., Chen, K., Huang, Z., Shields, H. W., King, S. B., Ballas, S. K., Nichols, J. S., Gladwin, M. T., Noguchi, C. T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205350200 · Cited by 24
The Watson-Crick Model and Reductionism
Schaffner, K. F. (1976) · Boston studies in the philosophy of science · doi:10.1007/978-94-010-1829-6_4 · Cited by 25
Relationship between wheat proteins
Booth, M. R., & Ewart, J. A. D. (1970) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.2740210406 · Cited by 24
Ball, J., Bradley, A., Le, A., Tisdale, J. F., & Uchida, N. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.016 · Cited by 31
Characterization of the binding of the anti-sickling compound, BW12C, to haemoglobin
Merrett, M., Stammers, D. K., White, R. D., Wootton, R., & Kneen, G. (1986) · Biochemical Journal · doi:10.1042/bj2390387 · Cited by 23
Plasma and urinary leukotrienes in sickle cell disease: possible role in the inflammatory process
Ibe, B. O., Kurantsin‐Mills, J., Raj, J. U., & Lessin, L. S. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb02060.x · Cited by 23
Clinical trials in sickle cell disease: Adopting the combination chemotherapy paradigm
Steinberg, M. H. (2007) · American Journal of Hematology · doi:10.1002/ajh.21033 · Cited by 26
Polygenic Basis and the Role of Genome Duplication in Adaptation to Similar Selective Environments
Campbell, M. A., Anderson, E. C., Garza, J. C., & Pearse, D. E. (2021) · Journal of Heredity · doi:10.1093/jhered/esab049 · Cited by 22
Woodard, K. J., Doerfler, P. A., Mayberry, K. D., Sharma, A., Levine, R. M., Yen, J. S., Valentine, V. A., Palmer, L. E., Valentine, M. B., & Weiss, M. J. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049463 · Cited by 27
“Sickle cell disease (SCD) is among the most common human monogenic disorders and the first one to be understood at the molecular level (Ingram, 1956; Kato et al., 2018; Pauling et al., 1949; Piel et al., 2017).”
Kehinde, M., Ogungbemi, S. I., Anigbogu, C. N., & Jaja, S. I. (2015) · Pathophysiology · doi:10.1016/j.pathophys.2015.05.001 · Cited by 22
The Long and Winding Road of Molecular Data in Phylogenetic Analysis
Suárez‐Díaz, E. (2013) · Journal of the History of Biology · doi:10.1007/s10739-013-9373-9 · Cited by 26
“To explain what caused the different electrical charge of HbS Ingram devised a new technique, based on Sanger’s approach to submit proteins to partial cleavage and incorporate paper chromatography (with a resulting two-dimensional chromatogram, Garcı́a-Sancho, 2010, p. 275).”
MethodInfluentialAN OVERVIEW ON SICKLE CELL DISEASE PROFILE
Kaur, M., Dangi, C. B. S., & Singh, M. (2013) · Cited by 22
The reaction of deoxy-sickle cell hemoglobin with hydroxyurea
Kim‐Shapiro, D. B., King, S. B., Shields, H. W., Kolibash, C. P., Gravatt, W. L., & Ballas, S. K. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00071-9 · Cited by 22
The cleavage of tyrosyl peptides by pepsin from collagen solubilised by the Nishihara technique
STEVEN, F. S. (1965) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(65)90158-3 · Cited by 22
Oblique alignment of hemoglobin S fibers in sickled cells
Edelstein, S. J., & Crepeau, R. H. (1979) · Journal of Molecular Biology · doi:10.1016/0022-2836(79)90491-1 · Cited by 22
Thin-layer peptide mapping: Quantitative analysis and sequencing at the nanomole level
Fishbein, J. C., Place, A. R., Ropson, I. J., Powers, D. A., & Sofer, W. H. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90712-5 · Cited by 22
Metadata
- Authors
- INGRAM, V. M.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- INGRAM, V. M.
- Venue
- Nature
- Published
- 1956-10
- Volume
- 178
- Issue
- 4537
- Pages
- 792-794
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2089819802
- Cited by
- 896
- References
- 12
- Citations by year
- 2026: 21 · 2025: 23 · 2024: 24 · 2023: 26 · 2022: 41 · 2021: 22 · 2020: 17 · 2019: 31 · 2018: 37 · 2017: 25 · 2016: 30 · 2015: 19 · 2014: 25 · 2013: 26 · 2012: 17
- FWCI
- 29.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- globin, sickle cell disease, hemoglobin, hemoglobin structure, hemoglobinopathies
- MeSH terms
- Anemia, Anemia, Sickle Cell, Globins, Hemoglobins, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.